Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

TSX:DHT.UN - Post Discussion

Dri Healthcare Trust > Another View
View:
Post by retiredcf on Nov 12, 2024 6:27am

Another View

It is a relatively small entity at market cap $741M, but priced well at 9X earnings. Units are up 5.5% this year and 25% over 52-weeks. Q3 revenue of $41.55M beat estimates of $39.9M. EBITDA was $31.3M. Net loss was 3c per unit. DHT.UN bought back $1.7M worth of units under its buyback. Loss declined from 9c last year. Adjusted cash earnings fell from 47c to 45c. It now has 26 royalty streams on 19 products. Two deals were closed subsequent to the quarter end. There were some serious management compliance issues in the summer (see prior answers) but these seem to have been addressed now. It has a decent record of distribution increases and is priced well. Still risky, but our views here have improved since July. (5iResearch)


Comment by raybay_98 on Nov 12, 2024 11:14am
"is priced well. Still risky" self explanatory! IPO was $10 USD Feb 19/21. US dollar price today $9.52. Nothing to write home in my books. jmho
Comment by HermannHaller on Nov 12, 2024 1:46pm
The fact that it is trading below IPO price, despite the multiple upgrades to the portfolio growth outlook, suggests it's great value still. jmho (note that they did pay a significant special distribution last year)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities